Sunesis Pharmaceuticals Inc(SNSS)
5.32
Change: -0.56 (▼ -10.51%)
As of Tue 12/20/2022 11:49 AM% Of Value
Growth
Value Per Share
:
:
:
-312.94
-64.57
-1.7000 (as of 24/02/2021)
NO DATA TO DISPLAY
Fundamentals Data
| Open | 4.67 | Dividend | 62 |
| Close Price | 5.32 | DivYield | 0 % |
| High | 7.0864 | Growth | -432,000.0 |
| Low | 4.67 | Growth% | -64.57 |
| P/e | -1.828 | Volume | 69.8 M |
| P/b | -2.89 | Market Capital | 182.7 M |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 50 Days Moving Average Percentage | 50.022556390977 (as of 08/12/2021 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2014 | Year2 / 2015 | Year3 / 2016 | Year4 / 2017 | Current Year / 2018 |
| Revenue | 5.7 M | 3.0 M | 2.5 M | 669,000.0 | 237,000.0 |
| Cap Spending | -48,000.0 | 0.0 | 0.0 | -26,000.0 | 0.0 |
| Operating Expenses | 50.7 M | 42.3 M | 38.9 M | 35.0 M | 25.9 M |
| Operating Cash Flow | -45.0 M | -39.3 M | -36.4 M | -34.4 M | -25.7 M |
| Free Cash Flow | -43.2 M | -38.7 M | -36.9 M | -36.1 M | -24.4 M |
| Free Cash Flow Per Share | -4.319 | -3.186 | -2.356 | -1.475 | -0.686 |
| Total liabilities | 9.2 M | 7.8 M | 14.4 M | 7.2 M | 7.3 M |
| Total cash | 22.1 M | 26.8 M | 8.0 M | 26.9 M | 13.6 M |
| ROE% | -2.914 | -1.998 | -2.894 | -2.768 | -2.756 |
| Outstanding Shares | 11.2 M | 14.4 M | 20.9 M | 34.3 M | 67.5 M |
| P/E | -3.655 | -1.368 | -2.311 | -4.107 | -1.828 |
| P/S | 27.408 | 16.393 | 34.654 | 217.697 | 205.301 |
| Revenue USD | 5.7 M | 3.0 M | 2.5 M | 669,000.0 | 237,000.0 |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|